|
1
|
Fahn S: Concept and classification of
dystonia. Adv Neurol. 50:1–8. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Spatola M and Wider C: Overview of primary
monogenic dystonia. Parkinsonism Relat Disord. 18(Suppl 1):
S158–S161. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kenney C and Jankovic J: Tetrabenazine in
the treatment of hyperkinetic movement disorders. Expert Rev
Neurother. 6:7–17. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Burke RE, Fahn S and Marsden CD: Torsion
dystonia: A double-blind, prospective trial of high-dosage
trihexyphenidyl. Neurology. 36:160–164. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Woon K, Tsegaye M and Vloeberghs MH: The
role of intrathecal baclofen in the management of primary and
secondary dystonia in children. Br J Neurosurg. 21:355–358. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Simpson DM, Blitzer A, Brashear A, Comella
C, Dubinsky R, Hallett M, Jankovic J, Karp B, Ludlow CL, Miyasaki
JM, et al: Therapeutics and Technology Assessment Subcommittee of
the American Academy of Neurology: Assessment: Botulinum neurotoxin
for the treatment of movement disorders (an evidence-based review):
Report of the Therapeutics and Technology Assessment Subcommittee
of the American Academy of Neurology. Neurology. 70:1699–1706.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lozano AM, Kumar R, Gross RE, Giladi N,
Hutchison WD, Dostrovsky JO and Lang AE: Globus pallidus internus
pallidotomy for generalized dystonia. Mov Disord. 12:865–870. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Vidailhet M, Vercueil L, Houeto JL,
Krystkowiak P, Lagrange C, Yelnik J, Bardinet E, Benabid AL,
Navarro S, Dormont D, et al: Bilateral, pallidal, deep-brain
stimulation in primary generalised dystonia: A prospective 3 year
follow-up study. Lancet Neurol. 6:223–229. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Tian ZM, Liu S, Li SY, Zhao QJ, Yin F, Hao
QX and Zhou Y: Clinical transplantation of human neural stem cells
in treatment of Parkinson disease. Di-Er Junyi Daxue Xuebao.
24:957–959. 2003.(In Chinese).
|
|
10
|
Yin F, Tian ZM, Liu S, Zhao QJ, Wang RM,
Shen L, Wieman J and Yan Y: Transplantation of human retinal
pigment epithelium cells in the treatment for Parkinson disease.
CNS Neurosci Ther. 18:1012–1020. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Tian ZM, Li ZC, Yin F, Li SY and Liu S:
Clinical transplantation of human neural stem cells in treatment of
cerebellar atrophy. Di-Er Junyi Daxue Xuebao. 25:933–935. 2004.(In
Chinese).
|
|
12
|
Lu WS, Tian ZM, Zhao QJ, Liu S, Li ZC,
Chen T and Guo XR: Clinical transplantation of human neural stem
cells in treatment of stroke sequelae: Report of 16 cases. Zhonghua
Shen Jing Wai Ke Ji Bing Yan Jiu Za Zhi. 7:502–504. 2008.(In
Chinese).
|
|
13
|
Andres RH, Choi R, Steinberg GK and Guzman
R: Potential of adult neural stem cells in stroke therapy. Regen
Med. 3:893–905. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Bacigaluppi M, Pluchino S, Martino G,
Kilic E and Hermann DM: Neural stem/precursor cells for the
treatment of ischemic stroke. J Neurol Sci. 265:73–77. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kondziolka D, Steinberg GK, Wechsler L,
Meltzer CC, Elder E, Gebel J, Decesare S, Jovin T, Zafonte R,
Lebowitz J, et al: Neurotransplantation for patients with
subcortical motor stroke: A phase 2 randomized trial. J Neurosurg.
103:38–45. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kondziolka D, Wechsler L, Goldstein S,
Meltzer C, Thulborn KR, Gebel J, Jannetta P, DeCesare S, Elder EM,
McGrogan M, et al: Transplantation of cultured human neuronal cells
for patients with stroke. Neurology. 55:565–569. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Nakao N, Kakishita K, Uematsu Y, Yoshimasu
T, Bessho T, Nakai K, Naito Y and Itakura T: Enhancement of the
response to levodopa therapy after intrastriatal transplantation of
autologous sympathetic neurons in patients with Parkinson disease.
J Neurosurg. 95:275–284. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Rabinovich SS, Seledtsov VI, Banul NV,
Poveshchenko OV, Senyukov VV, Astrakov SV, Samarin DM and Taraban
VY: Cell therapy of brain stroke. Bull Exp Biol Med. 139:126–128.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Savitz SI, Dinsmore JH, Wechsler LR,
Rosenbaum DM and Caplan LR: Cell therapy for stroke. NeuroRx.
1:406–414. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Suchowersky O: Transplantation therapy for
Parkinson disease: The good, the bad and the enigmatic. Nat Clin
Pract Neurol. 4:4652008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Al Hashem G, Al Sweih N, Jamal W and
Rotimi VO: Sequence analysis of bla (CTX-M) genes carried by
clinically significant Escherichia coli isolates in Kuwait
hospitals. Med Princ Pract. 20:213–219. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Burk RE, Fahn S, Marsden CD, Bressman SB,
Moskowitz C and Friedman J: Validity and reliability of a rating
scale for the primary torsion dystonias. Neurology. 35:73–77. 1985.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Tian ZM, Yin F, Wang YQ, Liu S and Zhou Y:
Transplantation of mesencephalon progenitor cells in treatment of
Parkinsonian rats. Di-Er Junyi Daxue Xuebao. 24:954–956. 2003.(In
Chinese).
|
|
24
|
Yin F, Zengmin T, Shuang L, Quanjun Z,
Yaming W and Qiuxing H: Local effects of dexamethasone on immune
reaction in neural transplantation. Transpl Immunol. 18:126–129.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ozelius LJ, Hewett JW, Page CE, Bressman
SB, Kramer PL, Shalish C, de Leon D, Brin MF, Raymond D, Corey DP,
Fahn S, Risch NJ, Buckler AJ, Gusella JF and Breakefield XO: The
early-onset torsion dystonia gene (DYT1) encodes an ATP-binding
protein. Nat Genet. 17:40–48. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Standaert DG: Update on the pathology of
dystonia. Neurobiol Dis. 42:148–151. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Lehéricy S, Tijssen MA, Vidailhet M, Kaji
R and Meunier S: The anatomical basis of dystonia: Current view
using neuroimaging. Mov Disord. 28:944–957. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Carbon M, Argyelan M and Eidelberg D:
Functional imaging in hereditary dystonia. Eur J Neurol. 17(Suppl
1): S58–S64. 2010. View Article : Google Scholar
|
|
29
|
Carbon M and Eidelberg D: Abnormal
structure-function relationships in hereditary dystonia.
Neuroscience. 164:220–229. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Trost M, Carbon M, Edwards C, Ma Y,
Raymond D, Mentis MJ, Moeller JR, Bressman SB and Eidelberg D:
Primary dystonia: Is abnormal functional brain architecture linked
to genotype? Ann Neurol. 52:853–856. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Riess P, Zhang C, Saatman KE, Laurer HL,
Longhi LG, Raghupathi R, Lenzlinger PM, Lifshitz J, Boockvar J,
Neugebauer E, et al: Transplanted neural stem cells survive,
differentiate and improve neurological motor function after
experimental traumatic brain injury. Neurosurgery. 51:1043–1052;
discussion 1052–1044. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Imitola J, Raddassi K, Park KI, Mueller
FJ, Nieto M, Teng YD, Frenkel D, Li J, Sidman RL, Walsh CA, et al:
Directed migration of neural stem cells to sites of CNS injury by
the stromal cell-derived factor 1alpha/CXC chemokine receptor 4
pathway. Proc Natl Acad Sci USA. 101:18117–18122. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wennersten A, Meier X, Holmin S, Wahlberg
L and Mathiesen T: Proliferation, migration and differentiation of
human neural stem/progenitor cells after transplantation into a rat
model of traumatic brain injury. J Neurosurg. 100:88–96. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Isacson O: The production and use of cells
as therapeutic agents in neurodegenerative diseases. Lancet Neurol.
2:417–424. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Lindvall O, Kokaia Z and Martinez-Serrano
A: Stem cell therapy for human neurodegenerative disorders-how to
make it work. Nat Med. 10(Suppl): S42–S50. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Martino G and Pluchino S: The therapeutic
potential of neural stem cells. Nat Rev Neurosci. 7:395–406. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Ubiali F, Nava S, Nessi V, Frigerio S,
Parati E, Bernasconi P, Mantegazza R and Baggi F: Allorecognition
of human neural stem cells by peripheral blood lymphocytes despite
low expression of MHC molecules: Role of TGF-beta in modulating
proliferation. Int Immunol. 19:1063–1074. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Barker CF and Billingham RE:
Immunologically privileged sites. Adv Immunol. 25:1–54. 1977.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Pachter JS, de Vries HE and Fabry Z: The
blood-brain barrier and its role in immune privilege in the central
nervous system. J Neuropathol Exp Neurol. 62:593–604. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
van den Berge SA, van Strien ME and Hol
EM: Resident adult neural stem cells in Parkinson's disease - the
brain's own repair system? Eur J Pharmacol. 719:117–127. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Yamada S, Kubota K, Kubota R, Ido T and
Tamahashi N: High accumulation of fluorine-18-fluorodeoxyglucose in
turpentine-induced inflammatory tissue. J Nucl Med. 36:1301–1306.
1995.PubMed/NCBI
|
|
42
|
Gonzalez-Alegre P, Bode N, Davidson BL and
Paulson HL: Silencing primary dystonia: Lentiviral-mediated RNA
interference therapy for DYT1 dystonia. J Neurosci. 25:10502–10509.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Tian ZM, Lu WS, Zhao QJ, Yu X, Xu YG, Wang
R and Qi SB: Clinical analysis of 1434 cases of frameless
stereotactic operation. Zhonghua Wai Ke Za Zhi. 45:702–704.
2007.(In Chinese). PubMed/NCBI
|
|
44
|
Walton NM, Snyder GE, Park D, Kobeissy F,
Scheffler B and Steindler DA: Gliotypic neural stem cells
transiently adopt tumorigenic properties during normal
differentiation. Stem Cells. 27:280–289. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Germano I, Swiss V and Casaccia P: Primary
brain tumors, neural stem cell and brain tumor cancer cells: Where
is the link? Neuropharmacology. 58:903–910. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Fan X, Matsui W, Khaki L, Stearns D, Chun
J, Li YM and Eberhart CG: Notch pathway inhibition depletes
stem-like cells and blocks engraftment in embryonal brain tumors.
Cancer Res. 66:7445–7452. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Abbott NJ, Ronnback L and Hansson E:
Astrocyte-endothelial interactions at the blood-brain barrier. Nat
Rev Neurosci. 7:41–53. 2006. View Article : Google Scholar : PubMed/NCBI
|
